KLF5 and neoplasm: KLF5 acts as a fundamental core regulator of intestinal oncogenesis at the stem-cell level, enhancing the nuclear localization and transcriptional activity of β-catenin, aiding tumor initiation (59), which is the target for a variety of antitumor drugs (60, 61).